iNO

Related by string. INO * * Inovio Biomedical AMEX INO . S. Inos . Secretary Eloy Inos . Eloy Inos . H. Inos . Deputy Ino Badillo . Innodata Isogen NASDAQ INOD . NYSE Amex INO . Nurses Organisation INO . assistant Ino Guerrero . Teppei Ino . NASDAQ INOD leading . 1C Ino Co . Neutrino Observatory INO . INO Records . AMEX INO . NASDAQ INOD . INO Therapeutics . Ino Patron . Ino Guerrero *

Related by context. All words. (Click for frequent words.) 68 inhaled nitric oxide 67 anagrelide 65 pentoxifylline 64 T1DM 64 DHA supplementation 64 recurrent venous thromboembolism 64 octreotide LAR 63 bronchopulmonary dysplasia 63 β blockers 63 colorectal adenoma 63 aldosterone antagonists 63 neurodevelopmental outcomes 63 divalproex sodium 63 euthyroid 62 nitroprusside 62 DMSA 62 GH deficiency 62 maximal doses 62 succimer 62 neurologic outcomes 62 postoperative delirium 62 sustained ventricular tachycardia 62 invasive aspergillosis 62 preterm neonates 62 beta blocker therapy 62 perioperatively 62 RAS blockers 62 polytherapy 62 steroid dexamethasone 62 tacrolimus ointment 62 inhaled budesonide 62 urate lowering therapy 62 COPD exacerbation 62 oral prednisolone 61 salmeterol fluticasone 61 persistent pulmonary hypertension 61 LNG IUS 61 serum estradiol 61 SSRI citalopram 61 nephrotoxic 61 leucopenia 61 paricalcitol 61 BPS IC 61 hyperoxia 61 artery calcification 61 acromegalic patients 61 nadroparin 61 racemic albuterol 61 corticosteroid therapy 61 IFN beta 61 bolus dose 61 systemic hypotension 61 type 1diabetes 61 attain statistical significance 61 pyridostigmine 60 relapsed MM 60 alteplase 60 corrected QT interval 60 postoperative AF 60 vasopressor 60 overactive bladder symptoms 60 breastfed infants 60 postprocedure 60 Postoperative complications 60 systemic corticosteroid 60 glomerular filtration 60 neurodevelopmental impairment 60 eosinophilic asthma 60 subclinical hypothyroidism 60 pelvic irradiation 60 neutropenic sepsis 60 flutamide 60 atorvastatin #mg 60 adjunctive placebo 60 Legg Calvé Perthes disease 60 interferon ribavirin 60 corticosteroid dose 60 bacteriuria 60 dosing cohort 60 reintubation 60 biochemical relapse 60 serum sodium levels 60 tolterodine 60 EXJADE 60 severe exacerbations 60 antibiotic rifaximin 60 paroxetine sertraline 60 Plasma concentrations 60 recurrent UTI 60 hepatorenal syndrome 60 IUGR 60 ximelagatran 60 transaminase elevations 60 endometrial hyperplasia 60 congenital hypothyroidism 60 nitrofurantoin 60 hours postdose 60 antithrombotic therapy 60 Intravenous immunoglobulin 60 intensive statin therapy 60 mutated K ras 60 blood Phe levels 60 everolimus eluting stents 60 comorbid ADHD 60 prolactin levels 60 clomipramine 59 thrombotic complications 59 elevated ALT 59 bronchoalveolar lavage fluid 59 dosing frequency 59 N acetylcysteine 59 atrioventricular block 59 dexmedetomidine 59 metabolic acidosis 59 etomidate 59 timepoints 59 external genital lesions 59 cranial irradiation 59 VT VF 59 RSV hospitalizations 59 milliliters mL 59 preterm deliveries 59 EDSS scores 59 TMP SMX 59 vesicoureteral reflux 59 oligohydramnios 59 advanced adenoma 59 colorectal liver metastases 59 TOPAMAX ® 59 AGHD 59 inhaled corticosteroids ICS 59 amoxicillin clavulanate 59 beta carotene supplementation 59 hyperbilirubinemia 59 LV dysfunction 59 NNT = 59 salmeterol fluticasone propionate 59 Inhaled nitric oxide 59 chorioamnionitis 59 nicardipine 59 nonsevere 59 FOSRENOL ® 59 ARB telmisartan 59 overt nephropathy 59 venous thromboembolic disease 59 MS relapses 59 #mg/day [002] 59 Insulin sensitivity 59 palivizumab 59 serum lipid levels 59 Heterozygous Familial Hypercholesterolemia 59 abacavir Ziagen 59 coronary stenosis 59 certolizumab 59 colorectal neoplasms 59 quetiapine Seroquel 59 acetaminophen toxicity 59 AGILECT R 59 solifenacin 59 status epilepticus 59 dexrazoxane 59 fructose intolerance 59 lanthanum carbonate 59 receiving XGEVA 59 acute gout flares 59 NPH insulin 59 acarbose 59 IOP lowering 59 anastomotic leak 59 dalteparin 59 PSA nadir 59 parkinsonian 59 venlafaxine XR 59 clodronate 59 atazanavir ritonavir 59 insulin glulisine 59 rFVIIa 59 Abrupt discontinuation 58 bronchodilatory 58 rebleeding 58 Heavy menstrual bleeding 58 asthma exacerbation 58 buprenorphine implants 58 ziconotide 58 thiopurine 58 PPCM 58 BENICAR HCT 58 definite stent thrombosis 58 perioperative complications 58 deep venous thromboses 58 SGRQ 58 gestational diabetes mellitus GDM 58 PPHN 58 chronic periodontitis 58 invasive candidiasis 58 alemtuzumab treated 58 rimonabant #mg 58 airway responsiveness 58 elevated transaminases 58 opioid dependent 58 #mg doses [002] 58 hypoglycemic episodes 58 aortic atherosclerosis 58 ß blockers 58 serum calcium levels 58 placebo dummy pill 58 HbA 1c levels 58 recombinant FSH 58 fluticasone salmeterol 58 oxcarbazepine 58 L. reuteri 58 chemoradiation therapy 58 Subarachnoid hemorrhage 58 recurrent VTE 58 bilirubin levels 58 PRADAXA #mg 58 adnexal mass 58 detemir 58 elevated creatinine 58 serum cortisol 58 viral titers 58 complete cytogenetic response 58 methotrexate monotherapy 58 Avandia Actos 58 intravenous morphine 58 perinatal asphyxia 58 nonvertebral fractures 58 intravenous tissue plasminogen 58 #mg/day [001] 58 daily subcutaneous injections 58 lamotrigine 58 bezafibrate 58 hyperammonemia 58 ICD shocks 58 symptom exacerbation 58 arterial thromboembolic events 58 neutrophil counts 58 neuroleptic 58 postnatally 58 desmopressin 58 symptomatic intracranial 58 Hypotension 58 cerebral vasospasm 58 nondiabetic patients 58 rtPA 58 fasting triglyceride levels 58 olmesartan 58 oral prednisone 58 neurodevelopmental outcome 58 COPD exacerbations 58 tegaserod 58 nadolol 58 torsade de pointes 58 gastroesophageal reflux GERD 58 nonischemic 58 proliferative retinopathy 58 neurologic impairment 58 pulmonary dysfunction 58 recurrent wheezing 58 selenium supplementation 58 symptomatic carotid stenosis 58 Zyban bupropion 58 Postoperatively 58 leukocyte count 58 plasma homocysteine 58 lipid lowering medications 58 mechanically ventilated patients 58 tachyarrhythmias 58 azoospermia 58 extubation 58 hypertonic saline 58 thromboprophylaxis 58 neurocognitive outcomes 58 epoetin alpha 58 betamethasone 58 HPA axis suppression 58 orofacial clefts 58 CONCERTA ® 58 posttreatment 58 CIPN 58 hematologic toxicity 58 SGPT 58 fetal malformations 58 antiandrogen 58 knee osteoarthritis OA 58 colesevelam HCl 58 4mg/kg 58 HIV HCV coinfected 58 undergoing coronary angiography 58 CI -#.# 58 ejection fractions 58 hyperthermic 58 teratogenic 58 biologic DMARD 58 transfusion syndrome 58 platelet dysfunction 58 hypoventilation 58 symptomatic VTE 58 antiarrhythmic drugs 58 renoprotective 58 PASI scores 58 artery stenosis 58 FluCAM arm 58 Atomoxetine 58 hyperalgesia 57 hypofractionated radiation 57 mild renal insufficiency 57 irregular menses 57 BLLs 57 folinic acid 57 montelukast 57 RISPERDAL ® 57 opioid naïve 57 dual endothelin receptor antagonist 57 dyslipidaemia 57 valvular heart disease 57 antioxidant supplementation 57 NYHA functional class 57 Infusion Reactions Severe 57 prolactin elevation 57 adenoma recurrence 57 Lipitor #mg 57 macrolide antibiotic 57 ALT elevations 57 baseline HbA1c 57 ELBW infants 57 intravenous bisphosphonates 57 clinically meaningful improvement 57 histologically proven 57 morphometric vertebral fractures 57 antidepressant paroxetine 57 atherogenic dyslipidemia 57 bronchial hyperresponsiveness 57 Teriflunomide 57 antidiabetic medication 57 % CI #.#-#.# [007] 57 persistent wheezing 57 ancrod 57 peripartum 57 μg d 57 antiarrhythmic drug 57 allergic eczema 57 acute STEMI 57 #mg dose [001] 57 reinfarction 57 EFFEXOR XR 57 pulmonary exacerbation 57 atopic disease 57 Serum creatinine 57 β blocker 57 rhinoconjunctivitis 57 methacholine challenge 57 postoperative morbidity 57 CIMZIA ™ 57 milrinone 57 Tranexamic acid 57 Thal Dex 57 % CI #.#-#.# [003] 57 von Willebrand 57 riociguat 57 menopausal hot flushes 57 CMV infection 57 renal scarring 57 interstitial fibrosis 57 cardiac repolarization 57 lactulose 57 polyp recurrence 57 magnesium sulphate 57 thrombocytopenic 57 radioiodine therapy 57 fibrinolysis 57 prolonged QT interval 57 QTc prolongation 57 cisplatin chemotherapy 57 QVAR R 57 EGFRIs 57 normotensive 57 pamidronate 57 vasodilatation 57 spirometric 57 dysmenorrhoea 57 posttransplant 57 cardiac perfusion 57 neurologic sequelae 57 nulliparous women 57 seroconverted 57 undetectable viral 57 Adjunctive 57 myocardial reperfusion 57 indomethacin 57 improves glycemic 57 intravenous tPA 57 glycated hemoglobin levels 57 epigastric pain 57 cefazolin 57 RRMS patients 57 risperidone Risperdal 57 benazepril 57 statins cholesterol lowering 57 haematologic 57 GBA mutations 57 Fasting plasma glucose 57 bosentan 57 hematopoietic cancers 57 μg kg 57 uridine triacetate 57 alpha1 antitrypsin deficiency 57 HbF 57 #mmHg [001] 57 potassium sparing diuretics 57 moderate renal impairment 57 SCIg 57 digoxin toxicity 57 gross hematuria 57 antiemetics 57 Apgar scores 57 brain lesions 57 myocardial infarct size 57 drank pomegranate juice 57 syncope fainting 57 anemia hemoglobin 57 nmol 57 Skin sterol 57 brachial plexus palsy 57 hyperphenylalaninemia HPA due 57 hemorrhagic cystitis 57 postoperative infections 57 VIIBRYD 57 Phenylketonuria PKU 57 Valproate 57 hypercholesterolaemia 57 SSRI SNRI 57 microvascular function 57 intracerebral haemorrhage 57 non aspirin NSAIDs 57 pyloric stenosis 57 metastatic malignant 57 atherosclerotic renal artery stenosis 57 bacterial prostatitis 57 transaminase levels 57 parasitemia 57 Serious adverse reactions 57 neuritic 57 deferiprone 57 systemic toxicity 57 pulmonary resection 57 FXIII 57 moderate hepatic impairment 57 HeFH 57 acetazolamide 57 virological response 57 MULTAQ 57 nocturnal hypoglycemia 57 fluid overload 57 NIHSS score 57 DAPT 57 fetal echocardiogram 57 bowel polyps 57 CLA supplementation 57 thiazide diuretic 57 sodium valproate 57 neurologic deficits 57 Neonates 57 interquartile range 57 aromatase inhibitor therapy 57 extubated 57 GG genotype 57 systolic dysfunction 57 ddI 57 hematologic parameters 57 Hepatotoxicity 57 paraprotein 57 Selective serotonin reuptake inhibitors 56 ATACAND 56 treprostinil 56 intermittent claudication 56 thromboembolic 56 thromboembolic complications 56 argatroban 56 lichen planus 56 nalbuphine 56 flecainide 56 serum homocysteine 56 advanced adenomas 56 antiplatelet drugs 56 upper gastrointestinal bleeding 56 systemic corticosteroids 56 antimuscarinic 56 Severe Primary IGFD 56 serum LDL cholesterol 56 inhaled bronchodilators 56 adenoidectomy 56 fibrinolytic therapy 56 Attention-Deficit/Hyperactivity Disorder ADHD 56 atypical neuroleptics 56 adrenal function 56 chromium supplementation 56 hypoxic ischemic encephalopathy 56 achieved ACR# 56 adrenal suppression 56 guideline concordant 56 oxycodone CR 56 neurosensory 56 monophasic 56 sitaxsentan 56 ropivacaine 56 resynchronization therapy 56 tenecteplase 56 ALT elevation 56 airway hyper responsiveness 56 apneic episodes 56 #mg dose [003] 56 invasive fungal infection 56 INVEGA ® 56 tipranavir r 56 #mg dose [002] 56 neonatal morbidity 56 salivary cortisol 56 unsupplemented 56 bronchoalveolar 56 GI motility 56 IM progesterone 56 serum phosphate 56 acute GvHD 56 pegaptanib 56 moderately emetogenic 56 NSAID induced 56 intermittent exotropia 56 salivary flow 56 asthma exacerbations 56 tamponade 56 normal birthweight 56 guanfacine 56 hemodilution 56 seropositivity 56 vasogenic edema 56 noncardiovascular mortality 56 eNO 56 LDB CPR 56 enamel defects 56 lavage fluid 56 #OHD levels 56 preoperative chemotherapy 56 ulcerative proctitis 56 conjunctival hyperemia 56 NMES 56 serum concentrations 56 PREZISTA r arm 56 acetylcysteine 56 insulin detemir 56 desvenlafaxine succinate 56 mcg QD 56 urinary cadmium 56 CHDs 56 varicella infection 56 decompensated heart failure 56 postoperative atrial fibrillation 56 intratympanic 56 rt PA 56 endometrial thickness 56 hypocalcaemia 56 ABCB1 56 DETROL LA 56 homocysteine concentrations 56 QTcF 56 cochlear implantation 56 aprepitant 56 habitual snoring 56 salmeterol HFA MDI 56 neonates 56 BoNTA 56 CLINICAL STUDIES 56 Nonspecific 56 nasal obstructions 56 prospectively stratified 56 APTIVUS r 56 OAB symptoms 56 glucocorticoid therapy 56 Perforomist Inhalation Solution 56 thromboembolism 56 choriocarcinoma 56 Creatinine 56 candidemia 56 lipid lowering agents 56 oral amoxicillin 56 atrophic gastritis 56 VLBW 56 Stent thrombosis 56 receiving ISENTRESS 56 pulmonary hypoplasia 56 CIMZIA TM certolizumab pegol 56 thiazide diuretics 56 simethicone 56 Paxil paroxetine 56 ALT flares 56 receiving prophylactic anticoagulation 56 extrapyramidal symptoms 56 ginkgo biloba extract 56 neuromuscular electrical stimulation 56 tracheal intubation 56 intermittent dosing 56 GnRH agonist 56 fluvastatin 56 parous women 56 chronic rhinosinusitis 56 inhaled corticosteroid therapy 56 plasma homocysteine levels 56 hemoglobin A1c HbA1c 56 exercise induced bronchoconstriction 56 hypervolemic 56 atherosclerotic progression 56 overt hypothyroidism 56 hypovolemia 56 Preterm infants 56 ergotamine 56 LAB CGRP 56 BYSTOLIC 56 cardiotoxic 56 NATRECOR ® 56 dysfunctional voiding 56 Clinically significant 56 silent ischemia 56 antithymocyte globulin 56 symptomatic intracranial hemorrhage 56 conjugated equine estrogens 56 cerebral oxygenation 56 serum bilirubin 56 ventricular tachycardia VT 56 % CI #.#-#.# [008] 56 oral rivaroxaban 56 intact parathyroid hormone 56 congenital toxoplasmosis 56 TOVIAZ 56 glatiramer acetate 56 ORENCIA ® 56 lung epithelium 56 intravenous bolus 56 prenatal multivitamin 56 adenotonsillectomy 56 gemifloxacin 56 reflux symptoms 56 aripiprazole Abilify 56 Toxicities 56 myocardial infarctions MIs 56 tympanostomy tubes 56 venlafaxine Effexor 56 FeNO 56 p ≤ 56 inotropic 56 idiopathic PAH 56 nortriptyline 56 weekly subcutaneous injections 56 trospium 56 edifoligide 56 sertraline Zoloft 56 thyroid deficiency 56 adrenocorticotropic hormone 56 ARCALYST ® 56 noscapine 56 prophylactic antibiotic 56 diabetic polyneuropathy 56 mitoxantrone plus 56 serum urate 56 arterial calcification 56 triacylglycerol concentrations 56 intravenous diuretics 56 TNF antagonist 56 neutropenic 56 triglyceride concentrations 56 ELBW 56 triiodothyronine 56 receptor blocker 56 receiving VICTRELIS 56 urine albumin 56 induce remission 56 born preterm 56 WBPA 56 eosinophil count 56 neurocognitive deficits 56 bypass grafting 56 antipyretics 56 serum urate levels 56 VTEs 56 RLAI 56 utero exposure 56 CYP#D# inhibitor 56 bexarotene 56 interstitial pneumonitis 56 long acting bronchodilator 56 postoperative complication 56 nonpregnant women 56 nephrotoxicity 56 diabetic gastroparesis 56 tolterodine ER 56 serum IgE 56 miconazole 56 pulmonary artery banding 56 calcium antagonists 56 Wistar rats 56 p = NS 56 angioneurotic edema 56 operable pancreatic cancer 56 paroxetine Paxil 56 selegiline 56 submaximal exercise 56 diabetic kidney 56 mu opioid 56 serum BDNF 56 BMPR2 55 aneurysmal subarachnoid hemorrhage 55 Hydroxyurea 55 imipramine Tofranil 55 hepatic toxicity 55 μmol L 55 serum IGF 55 LYSTEDA 55 postoperative infection 55 myocardial dysfunction 55 prostanoid 55 methemoglobinemia 55 daytime alertness 55 MYLOTARG 55 saline infusion 55 procalcitonin 55 pyelonephritis 55 mepolizumab 55 dapagliflozin plus 55 beclomethasone dipropionate 55 histologic subtype 55 iron supplementation 55 oral hypoglycemic 55 hip resurfacing arthroplasty 55 acute respiratory tract infections 55 #OHD 55 underactive thyroids 55 platelet inhibition 55 tiotropium bromide 55 interstitial pneumonia 55 atopic eczema 55 cinacalcet 55 5-FU/LV 55 postoperative hemorrhage 55 Exacerbation 55 GI toxicity 55 RSV infections 55 autoantibody positive 55 neonatal jaundice 55 placental malaria 55 BPH LUTS 55 sonographic diagnosis 55 AUC0 55 nonvertebral fracture 55 bronchopulmonary dysplasia BPD 55 intrapartum 55 immunomodulatory agents 55 urolithiasis 55 piroxicam 55 AA Amyloidosis 55 Venlafaxine 55 NATRECOR R 55 hypophosphatemia 55 dobutamine 55 preterm newborns 55 pharmacologic treatments 55 Symptom severity 55 intracerebral 55 nanograms milliliter 55 serum parathyroid hormone 55 urinary cortisol 55 intima media thickness 55 CrCl 55 clinically meaningful improvements 55 somatostatin analogs 55 seroprotective 55 ventilatory 55 hMG 55 troponin T 55 CMV reactivation 55 surgically induced 55 carotid IMT 55 CPAP adherence 55 genital herpes infections 55 ventricular fibrillation VF 55 experimentally induced 55 Eisenmenger syndrome 55 plasma cortisol 55 recurrent atrial fibrillation 55 hyperinsulinemic 55 cerebral infarction 55 antidiabetic drugs 55 conjugated estrogen 55 hepatotoxicity 55 neurocognitive impairment 55 MMP inhibitor 55 achieved CCyR 55 SHBG levels 55 intra articular injection 55 fructose intolerant 55 mcg BID 55 multivariable analysis 55 COPEGUS therapy 55 postoperative mortality 55 coronary occlusion 55 perimenopausal women 55 anthracycline chemotherapy 55 antibiotic prophylaxis 55 mesalamine granules 55 Febrile neutropenia 55 constipation predominant IBS 55 enzyme elevations 55 androgen deprivation 55 alkalosis 55 airway hyperresponsiveness 55 pancreatic fistula 55 ZOLINZA 55 haloperidol Haldol 55 BEXXAR Therapeutic Regimen 55 EDSS score 55 ADHD stimulant 55 exhaled nitric oxide 55 oral antidiabetes 55 terazosin 55 antiepileptic drugs AEDs 55 mucosal inflammation 55 thyrotropin levels 55 Interferon beta 1b 55 Flu Cy 55 ULORIC 55 oral naltrexone 55 aspartate aminotransferase 55 mechanically ventilated 55 NIH CPSI 55 MenACWY 55 CC genotype 55 graft occlusion 55 inhaled fluticasone 55 ziprasidone Geodon 55 metabolic syndrome MetS 55 intradermal injections 55 recurrent DVT 55 SUVmax 55 overnight polysomnography 55 esophageal reflux 55 primary aldosteronism 55 neutropenic fever 55 spontaneous preterm delivery 55 RSV replication 55 Pioglitazone 55 metastatic gastric 55 chronic GVHD 55 % Confidence Interval 55 calcineurin inhibitor 55 Calcium intake 55 precancerous condition 55 zafirlukast 55 inflammatory biomarkers 55 Glatiramer acetate 55 neutropaenia 55 lipid lowering therapy 55 heFH 55 latanoprost 55 antirheumatic 55 VLBW infants 55 delayed gastric emptying 55 bupropion Wellbutrin 55 post thrombotic syndrome 55 metformin accumulation 55 hyperemesis 55 serum sodium 55 leukoencephalopathy 55 low dose Iluvien 55 lipid lowering medication 55 hemoptysis 55 hyperhomocysteinemia 55 bleomycin 55 haemorrhagic stroke 55 antiphospholipid antibodies 55 anthracycline therapy 55 comorbid anxiety 55 bioavailable testosterone 55 serum retinol 55 antibody titer 55 poststroke depression 55 cis retinoic acid 55 Imipramine 55 bovine thrombin 55 tolvaptan 55 severe hyperbilirubinemia 55 dysglycemia 55 depressive relapse 55 GERD symptoms 55 serum PTH 55 electrical cardioversion 55 HMG CoA reductase inhibitors 55 renal toxicity 55 syncopal episodes 55 paresthesias 55 anticholinergic medication 55 sensory neuropathy 55 postintervention 55 remifentanil 55 elevated LDH 55 concomitant medications 55 sotalol 55 mycophenolate 55 mycophenolic acid 55 virologic failure 55 recurrent ischemia 55 poor metabolizers 55 antenatal depression 55 prescribed antipsychotics 55 inotropes 55 familial hypercholesterolemia 55 periprocedural 55 parkinsonian symptoms 55 beta interferons 55 MMSE scores 55 hypocaloric diet 55 NIHSS 55 nonexposed 55 pretest probability 55 cortical activation 55 cerebral venous thrombosis 55 neurologic complications 55 retransplantation 55 Oral corticosteroids 55 atopic 55 thyroid hormone replacement 55 perinatal complications 55 albumin excretion 55 NNRTI resistance 55 Postoperative 55 Nifedipine 55 testicular tumors 55 chlorambucil 55 coagulation abnormalities 55 polycystic 55 non splenectomized 55 metastatic GIST 55 QD dosing 55 mL/min/#.# m 2 55 folic acid supplementation 55 thoracoscopy 55 prepubertal 55 esophageal acid 55 coronary artery occlusion 55 hyperresponsiveness 55 CANCIDAS 55 de ath 55 Intussusception 55 low birthweights 55 bacteremic 55 mg kg dose 55 severe hypoglycaemia 55 hyperacute 55 infused intravenously 55 carvedilol 55 STEP BD 55 LTRA 55 hyperoxaluria 55 timolol maleate 55 periventricular leukomalacia 55 hypoperfusion 55 glucose tolerance test 55 C#BL/#J mice 55 kidney insufficiency 55 conventional DMARDs 55 atypical antipsychotic medications 55 MAS XR 55 AZT zidovudine Retrovir 55 urodynamic 55 nitrosothiols 55 diabetes mellitus DM 55 asthmatic symptoms 55 desipramine 55 intestinal permeability 55 cranial radiation 55 blood phenylalanine Phe 55 Plaquenil 55 VUR 55 pCR 55 comparator arm 55 ZD# [001] 55 pouchitis 55 adrenalectomy 55 Hb A1C 55 tranylcypromine 55 metabolizer 55 gestational hypertension 55 H2 blocker 55 fructose diet 55 Lactobacillus KW 55 prucalopride 55 symptomatic hypotension 55 oxygen saturations 55 MEVACOR 55 #β estradiol 55 MAGE A3 ASCI 55 lumbar disk herniation

Back to home page